PT  - JOURNAL ARTICLE
ED  - ,
TI  - Cimetidine
AID  - 10.1136/dtb.17.8.29
DP  - 1979 Apr 13
TA  - Drug and Therapeutics Bulletin
PG  - 29--32
VI  - 17
IP  - 8
4099  - http://dtb.bmj.com/content/17/8/29.short
4100  - http://dtb.bmj.com/content/17/8/29.full
SO  - Drug Ther Bull1979 Apr 13; 17
AB  - Cimetidine (Tagamet - SKF) is the first histamine-H2 receptor antagonist in general use. It reduces gastric acid secretion and is marketed for the treatment of duodenal ulcer, benign gastric ulcer, recurrent and stomal ulceration, reflux oesophagitis and Zollinger-Ellison syndrome.